Clincosm LogoSign in Get a demo

Pancreatic Adenocarcinoma

Showing 51 - 75 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colon Adenocarcinoma
  • +6 more
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jul 28, 2022

Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)

Recruiting
  • Pancreatic Adenocarcinoma
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jul 15, 2022

Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

Recruiting
  • Mesothelioma
  • +14 more
  • TC-510
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 14, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Pancreatic Adenocarcinoma Trial in Palo Alto (procedure, biological, drug)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fluorescence Imaging
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

Recruiting
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Singapore, Singapore
    National Cancer Centre
Jun 10, 2022

Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 7, 2022

Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Odense

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
    • Odense, Denmark
      Odense University Hospital
    Jun 5, 2022

    Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Milan (EUS-guided Portal Vein sampling)

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • EUS-guided Portal Vein sampling
    • Milan, Italy
      IRCCS San Raffaele Scientific Institute
    Jun 2, 2022

    Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)

    Active, not recruiting
    Has Results
    • Pancreatic Adenocarcinoma
    • Calgary, Alberta, Canada
    • +26 more
    May 9, 2022

    Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma Trial in Germany (Romidepsin, Azacitidine,

    Recruiting
    • Pancreas Cancer
    • +2 more
    • Essen, Germany
    • +8 more
    May 17, 2022

    Metastatic Pancreas Cancer, Locally Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Worldwide (EndoTAG-1,

    Completed
    • Metastatic Pancreas Cancer
    • +2 more
    • Corona, California
    • +67 more
    Apr 28, 2022

    Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)

    Not yet recruiting
    • Pancreas Cancer
    • +5 more
    • Laparoscopic surgical biopsy and organoid generation
    • (no location specified)
    Apr 22, 2022

    Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • Modified GCN+TTF treatment
    • Jacksonville, Florida
      Mayo Clinic
    Apr 4, 2022

    Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using

    Completed
    • Pancreatic Tumor, Benign
    • +13 more
    • Distal Pancreatectomy Sealing Using LTW
    • Houston, Texas
      Baylor CHI St. Luke's Medical Center
    Apr 4, 2022

    Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

    Recruiting
    • Pancreatic Adenocarcinoma
    • +3 more
    • Stockholm, Sweden
    • +1 more
    Apr 4, 2022

    Pancreatic Adenocarcinoma Trial in Philadelphia (Niraparib + Nivolumab, Niraparib + Ipilimumab)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • Niraparib + Nivolumab
    • Niraparib + Ipilimumab
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Abramson Cancer Center
    Mar 23, 2022

    Pancreatic Cancer Biomarker Study

    Recruiting
    • Pancreatic Adenocarcinoma
      • Grand Rapids, Michigan
        Mercy Health Saint Mary's Hospital
      Apr 1, 2022

      Pancreatic Adenocarcinoma, Interventional Imaging Trial in Poitiers (NanoKnife)

      Completed
      • Pancreatic Adenocarcinoma
      • Interventional Imaging
      • NanoKnife
      • Poitiers, France
        CHU Poitiers
      Mar 29, 2022

      Germline Mutations Associated With Hereditary Pancreatic Cancer

      Recruiting
      • Pancreatic Cancer
      • Pancreatic Adenocarcinoma
      • Invitae Multi-Cancer Panel ®
      • Mexico City, Mexico
        Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
      Mar 22, 2022

      Metastatic Colorectal Cancer, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Washington (Durvalumab, CV301,

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • +3 more
      • Washington, District of Columbia
        Lombardi Comprehensive Cancer Center
      Mar 15, 2022

      Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States

      Active, not recruiting
      • Pancreatic Adenocarcinoma
      • +3 more
      • Gemcitabine Hydrochloride
      • +5 more
      • Duarte, California
      • +3 more
      Mar 17, 2022

      PAncreatic Adenocarcinoma in Hospital

      Completed
      • Pancreatic Adenocarcinoma
        • Jolimont, Belgium
        • +65 more
        Mar 11, 2022

        Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

        Active, not recruiting
        • Pancreatic Cancer
        • +2 more
        • Nab-paclitaxel and gemcitabine for R-PDAC Patients
        • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
        • Scottsdale, Arizona
        • +3 more
        Mar 8, 2022

        Pancreatic Adenocarcinoma Trial in Kochi (GS, GnP)

        Recruiting
        • Pancreatic Adenocarcinoma
        • Kochi, Japan
          Takehiro Okabayashi
        Feb 24, 2022